Insider sale
FULCRUM THERAPEUTICS, INC.
$54.24M
4.18M shares
What this filing means
RA CAPITAL HEALTHCARE FUND LP plans to sell 4.18M shares of FULCRUM THERAPEUTICS, INC. valued at approximately $54.24M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001178937-25-000086
10% Owner
Since Aug 2022
4.18M
Shares to sell
$54.24M
Approx. market value
4.18M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Open Market Purchases
Wire
9/12/2024
1.07MSecondary
Wire
1/18/2023
1.11MSecondary
Wire
8/16/2022
2MTotal acquired4.18M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2024 | Open Market Purchases Wire | 1.07M | — |
1/18/2023 | Secondary Wire | 1.11M | — |
8/16/2022 | Secondary Wire | 2M | — |
| Total | 4.18M | ||
Planned & Completed Dispositions1
NASDAQ GMPlanned
Units to sell
4.18M
Market value
$54.24M
12/8/2025
Total
Units
4.18M
Value
$54.24M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/8/2025 | 4.18M | $54.24M | NASDAQ GM | Planned |
| Total | 4.18M | $54.24M | ||